NCI, SITC immunotherapy fellowship calls for applications

Supreme Court lifts lower-court freeze on RIFs

The U.S. Supreme Court has temporarily lifted a lower court’s freeze on the Trump administration’s reductions in force, or RIFs, freeing the government to continue their large-scale restructuring of the federal government.

Steroids may make immunotherapy less effective for lung cancer patients, retrospective study finds

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer patients treated with immunotherapy, are the main reason certain immunotherapies may fail in treating the disease, according to research led by researchers at Keck Medicine of USC.

July 11, 2025

Vol.51 No.27

Clinical Roundup

Common autoimmune drug may help reverse immunotherapy-induced diabetes, UCLA preclinical study finds

A team of researchers at the UCLA Health Jonsson Comprehensive Cancer Center has identified a potential new strategy to prevent, and even reverse, immune checkpoint inhibitor-induced type 1 diabetes using an existing class of autoimmune drugs.

July 11, 2025

Vol.51 No.27

Guest Editorial

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

We recently had the privilege of contributing to a CBS Sunday Morning story on the ongoing crisis in the federal support for research in general and cancer research in particular.

July 03, 2025

Vol.51 No.26

By George J. Weiner and Elizabeth M. Jaffee

Clinical Roundup

Rare pancreatic cancer shows strong response to immunotherapy

New research shows that a rare group of pancreatic cancer patients responded remarkably well to immunotherapy, a treatment typically considered ineffective for this cancer type.

July 03, 2025

Vol.51 No.26

In Brief

RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients

RWJBarnabas Health and Rutgers Cancer Institute officially opened the doors of the 12-story, 520,000 square-foot, state-of-the-art Jack & Sheryl Morris Cancer Center—the state’s only freestanding, comprehensive cancer hospital, one of just 13 in the nation.

June 27, 2025

Vol.51 No.25

NCI, SITC immunotherapy fellowship calls for applications

YOU MAY BE INTERESTED IN

Supreme Court lifts lower-court freeze on RIFs

Steroids may make immunotherapy less effective for lung cancer patients, retrospective study finds

Common autoimmune drug may help reverse immunotherapy-induced diabetes, UCLA preclinical study finds

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures

Rare pancreatic cancer shows strong response to immunotherapy

RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients

Renew today!

Subscriber content

Never miss an issue!

Login

NCI, SITC immunotherapy fellowship calls for applications

YOU MAY BE INTERESTED IN

Supreme Court lifts lower-court freeze on RIFs

Steroids may make immunotherapy less effective for lung cancer patients, retrospective study finds

Common autoimmune drug may help reverse immunotherapy-induced diabetes, UCLA preclinical study finds

As cancer scientists, we must change how we engage with the public on the impact of NIH cutsWhat the scientific method obscures

Rare pancreatic cancer shows strong response to immunotherapy

RWJBarnabas Health, Rutgers Cancer Institute welcomes first patients

Never miss an issue!

Login

As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures